3Shape A/S and Medit Corp. Reach Settlement in Patent Infringement Lawsuit

2024-11-22 3Shape HaiPress

COPENHAGEN,Denmark,Nov. 21,2024 -- 3Shape A/S,a global innovator in digital dentistry with its market-leadingintraoral (IOS) scanners,and Medit Corp,a leading provider of dental 3D scanners,today announced they have settled U.S. patent infringement litigation.

Both companies are committed to moving forward constructively and focusing on their core business priorities.

"3Shape is pleased to have resolved this matter and move forward without further litigation," said Henriette Stakemann,3Shape General Counsel. "Our focus remains on protecting our intellectual property while continuing to innovate and deliver value to our customers."

Media Contact:


Jessica O'Sullivan-Munck


Director of Corporate Communications


jessica.osullivanmunck@3shape.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/3shape/r/3shape-a-s-and-medit-corp--reach-settlement-in-patent-infringement-lawsuit,c4069152

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map